Janssen-Cilag Ltd Clinical Trial
Janssen-Cilag Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
30
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Janssen-Cilag Ltd Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:21 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06472778 · A Real-world Study in Participants With Smoldering Multiple MyelomaJanssen-Cilag Ltd. · completed · Smoldering Multiple Myeloma · study director
- Ph3NCT06408935 · Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease PatientsJanssen-Cilag Ltd. · active not recruiting · Crohn's Disease
- N/ANCT05901649 · A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or EnzalutamideJanssen-Cilag Ltd. · completed · Metastatic Hormone-sensitive Prostate Cancer · study director
- Ph3NCT05347095 · A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseJanssen-Cilag Ltd. · active not recruiting · Fistulizing Crohns Disease, Perianal Crohns Disease · study director
- Ph4NCT05125679 · Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque PsoriasisJanssen-Cilag Ltd. · terminated · Psoriasis · study director
- N/ANCT04829669 · A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric EmergencyJanssen-Cilag Ltd. · withdrawn · Depressive Disorder, Major · study director
- Ph4NCT04829318 · A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentJanssen-Cilag Ltd. · completed · Depressive Disorder, Major · study director
- N/ANCT04232228 · A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care ProvidersJanssen-Cilag Ltd. · terminated · Crohn Disease · study director
- N/ANCT04035226 · A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody TreatmentJanssen-Cilag Ltd. · completed · Multiple Myeloma · study director
- Ph3NCT03998683 · A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular PsoriasisJanssen-Cilag Ltd. · completed · Psoriasis · study director
- N/ANCT03955900 · A Registry Study of Participants With Multiple Myeloma in Latin AmericaJanssen-Cilag Ltd. · completed · Multiple Myeloma · study director
- Ph3NCT03782376 · A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's DiseaseJanssen-Cilag Ltd. · completed · Crohn Disease · study director
- N/ANCT03495973 · Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's DiseaseJanssen-Cilag Ltd. · completed · Crohn Disease · study director
- N/ANCT03425591 · A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical PracticeJanssen-Cilag Ltd. · completed · Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell · study director
- N/ANCT03373253 · Treatment-Resistant Depression Cohort in EuropeJanssen-Cilag Ltd. · completed · Depressive Disorder, Treatment-Resistant · study director
- Ph3NCT03107793 · Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With UstekinumabJanssen-Cilag Ltd. · completed · Crohn Disease
- N/ANCT02874560 · Evaluation of the Functional Remission Occurrence and Predictive Factors in SchizophreniaJanssen-Cilag Ltd. · completed · Schizophrenia · study director
- N/ANCT02773394 · Study to Describe the Actual Situation of Hepatitis C Treatment in BrazilJanssen-Cilag Ltd. · completed · Hepatitis C Virus · study director
- N/ANCT02712463 · A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With AntipsychoticsJanssen-Cilag Ltd. · completed · Schizophrenia · study director
- N/ANCT02597270 · An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV InfectionJanssen-Cilag Ltd. · completed · Hepatitis C Virus · study director
- N/ANCT02559583 · Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin AmericaJanssen-Cilag Ltd. · completed · Multiple Myeloma, Leukemia, Lymphoid · study director
- Ph4NCT02385058 · Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationJanssen-Cilag Ltd. · completed · Helminthiasis, Amoebiasis · study director
- Ph4NCT01855074 · An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersJanssen-Cilag Ltd. · completed · Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder · study director
- N/ANCT01836874 · A Study of Prophylaxis for Migraine Patients With Topiramate in IndiaJanssen-Cilag Ltd. · completed · Migraine · study director
- Ph4NCT01726335 · Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With SchizophreniaJanssen-Cilag Ltd. · completed · Schizophrenia · study director
- N/ANCT01030159 · National Cancer Institute Thai Cancer Anemia SurveyJanssen-Cilag Ltd.,Thailand · completed · Anemia, Cancer · study director
- N/ANCT01018043 · Thai Cancer Anemia Survey in Chulalongkorn HospitalJanssen-Cilag Ltd.,Thailand · completed · Anemia, Cancer · study director
- Ph4NCT00771199 · An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer PainJanssen-Cilag Ltd. · completed · Cancer, Pain · study director
- Ph4NCT00766506 · An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic SurgeryJanssen-Cilag Ltd. · terminated · Pain, Postoperative · study director
- Ph3NCT00254930 · A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenJanssen-Cilag Ltd. · completed · Learning Disorders, Child Behavior Disorders · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.